Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003480906 | SCV001197752 | likely benign | not provided | 2025-01-20 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002552057 | SCV003721158 | uncertain significance | Inborn genetic diseases | 2024-11-13 | criteria provided, single submitter | clinical testing | The c.1860G>A (p.M620I) alteration is located in exon 16 (coding exon 16) of the TRAF3IP1 gene. This alteration results from a G to A substitution at nucleotide position 1860, causing the methionine (M) at amino acid position 620 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV003480906 | SCV004226037 | uncertain significance | not provided | 2022-11-22 | criteria provided, single submitter | clinical testing | BP4 |